Boyar Asset Management Inc. Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Boyar Asset Management Inc. grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,304 shares of the company’s stock after acquiring an additional 986 shares during the period. Boyar Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $413,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Pathway Financial Advisers LLC acquired a new stake in shares of GE HealthCare Technologies during the 1st quarter worth approximately $25,000. BNP Paribas purchased a new stake in GE HealthCare Technologies during the first quarter worth $30,000. Rise Advisors LLC grew its position in GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after buying an additional 239 shares during the period. Riverview Trust Co acquired a new stake in GE HealthCare Technologies during the first quarter valued at $31,000. Finally, Annapolis Financial Services LLC grew its position in shares of GE HealthCare Technologies by 171.9% during the 1st quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock valued at $32,000 after acquiring an additional 220 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on GEHC. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price for the company. Finally, Stifel Nicolaus assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target on the stock. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $95.00.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares in the company, valued at approximately $1,414,377.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Down 2.5 %

GEHC stock opened at $85.09 on Friday. The firm has a market cap of $38.84 billion, a PE ratio of 24.88, a PEG ratio of 3.17 and a beta of 1.17. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The firm’s 50 day moving average price is $82.09 and its 200-day moving average price is $83.52.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same period last year, the company earned $0.92 EPS. The company’s quarterly revenue was up .5% on a year-over-year basis. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.